Gencor and Pharmako Biotechnologies are pleased to announce the latest patent for HydroCurc, a clinically proven, award-winning, cold-water dispersible curcumin. The newly granted patent titled “LIQUID DISPERSIBLE CURCUMINOID COMPOSITIONS AND METHODS OF IMPROVING COGNITIVE FUNCTION” covers the clinical data backing HydoCurc®’s ability to improve bioavailability and increase the serum levels of brain-derived neurotrophic factor (BDNF). It also states, “This effect is further enhanced when the dispersible curcuminoid composition is combined with, or co-administered with, an iron supplement.”
HydroCurc’s increased bioavailability is due to Pharmako's proprietary and patented LipiSperse® delivery technology. LipiSperse is a novel system tailored to improve the dispersion of crystalline lipophilic agents in aqueous environments. LipiSperse® acts on the powder surface and converts it from lipophilic to hydrophilic. Due to its unique functionality, HydroCurc® delivers 90% of the active ingredient and can be incorporated into several applications, such as powder, tablets, capsules, gels, sachets, effervescents, drinks, shots, and more, helping to solve the bioavailability and functionality challenges with curcumin.
“We are thrilled about this new patent for HydroCurc. This is the first study to demonstrate that an orally taken, highly bioavailable curcumin (HydroCurc) coupled with iron was able to increase Brain-Derived Neurotrophic Factor (BDNF). BDNF is a protein that plays a critical role in the development, growth, and maintenance of neurons in the brain,” said George Kokkinis, CEO & Founder of Pharmako Biotechnologies. Kokkinis continued, “Some key points include:
- Neuroplasticity is the brain's ability to reorganise itself by forming new neural connections. It is essential for learning and memory. BDNF is vital for neuroplasticity;
- Survival and growth: BDNF helps support the survival of existing neurons and encourages the growth and differentiation of new neurons and synapses;
- Mental health: low levels of BDNF have been linked to various mental health conditions, including depression and anxiety. Increasing BDNF levels can potentially improve mood and cognitive function.”
HydroCurc® is clinically validated to support cognitive function, joint health, sports and exercise recovery, and more. To review the published clinical data and for more information on HydroCurc®, visit https://www.hydrocurc.com/ or GencorPacific.com.
HydroCurc® and LipiSperse® are registered trademarks of Pharmako Biotechnologies